Literature DB >> 25907537

TRIM35 negatively regulates TLR7- and TLR9-mediated type I interferon production by targeting IRF7.

Yanming Wang1, Shanshan Yan1, Bo Yang1, Yan Wang2, Haiyan Zhou3, Qiaoshi Lian3, Bing Sun4.   

Abstract

Toll-like receptor 7 (TLR7) and TLR9 sense viral nucleic acids and induce type I IFN production, which must be properly controlled to avoid autoimmune diseases. Here, we report the negative regulation of TLR7/9-mediated type I IFN production by TRIM35. TRIM35 expression is induced by TLR7/9 stimulation and then interacts with IRF7, which is the master regulator of type I IFN response. Furthermore, TRIM35 promotes the K48-linked ubiquitination of IRF7 and induces its degradation via a proteasome-dependent pathway. Therefore, TRIM35 is a negative feedback regulator of TLR7/9-mediated type I IFN production due to its ability to suppress the stability of IRF7.
Copyright © 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Feedback regulation; IRF7; K48-linked ubiquitination; Proteasome-dependent degradation; TLR7/9; TRIM35

Mesh:

Substances:

Year:  2015        PMID: 25907537     DOI: 10.1016/j.febslet.2015.04.019

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  16 in total

Review 1.  TRIMs: selective recruitment at different steps of the NF-κB pathway-determinant of activation or resolution of inflammation.

Authors:  Milton Roy; Rajesh Singh
Journal:  Cell Mol Life Sci       Date:  2021-07-20       Impact factor: 9.261

2.  TLR8 Couples SOCS-1 and Restrains TLR7-Mediated Antiviral Immunity, Exacerbating West Nile Virus Infection in Mice.

Authors:  Amber M Paul; Dhiraj Acharya; Linda Le; Penghua Wang; Dobrivoje S Stokic; A Arturo Leis; Lena Alexopoulou; Terrence Town; Richard A Flavell; Erol Fikrig; Fengwei Bai
Journal:  J Immunol       Date:  2016-10-21       Impact factor: 5.422

3.  Cellular FLIP long isoform (cFLIPL)-IKKα interactions inhibit IRF7 activation, representing a new cellular strategy to inhibit IFNα expression.

Authors:  Lauren T Gates-Tanzer; Joanna L Shisler
Journal:  J Biol Chem       Date:  2017-12-08       Impact factor: 5.157

4.  Duck Tembusu Virus Inhibits Type I Interferon Production through the JOSD1-SOCS1-IRF7 Negative-Feedback Regulation Pathway.

Authors:  Shanzhi Huang; Juan Huang; Min Cui; Xuedong Wu; Mingshu Wang; Dekang Zhu; Shun Chen; Mafeng Liu; Xinxin Zhao; Ying Wu; Qiao Yang; Shaqiu Zhang; Xumin Ou; Sai Mao; Qun Gao; Yanling Yu; Bin Tian; Yunya Liu; Ling Zhang; Zhongqiong Yin; Bo Jing; Xiaoyue Chen; Anchun Cheng; Renyong Jia
Journal:  J Virol       Date:  2022-09-07       Impact factor: 6.549

5.  Tripartite motif-containing 35 (TRIM35) is up-regulated in UUO-induced renal fibrosis animal model.

Authors:  Yu Chen; Yue Ding; Li-Ming Wang
Journal:  Histol Histopathol       Date:  2020-09-21       Impact factor: 2.303

6.  Tripartite-motif family protein 35-28 regulates microglia development by preventing necrotic death of microglial precursors in zebrafish.

Authors:  Tao Yu; Haoyue Kuang; Jiahao Chen; Xi Lin; Yi Wu; Keyu Chen; Mingjie Zhang; Wenqing Zhang; Zilong Wen
Journal:  J Biol Chem       Date:  2020-05-12       Impact factor: 5.157

7.  miR-4417 Targets Tripartite Motif-Containing 35 (TRIM35) and Regulates Pyruvate Kinase Muscle 2 (PKM2) Phosphorylation to Promote Proliferation and Suppress Apoptosis in Hepatocellular Carcinoma Cells.

Authors:  Lijie Song; Weijie Zhang; Zhiwei Chang; Yanfeng Pan; Hong Zong; Qingxia Fan; Liuxing Wang
Journal:  Med Sci Monit       Date:  2017-04-10

Review 8.  Viruses Seen by Our Cells: The Role of Viral RNA Sensors.

Authors:  Elias A Said; Nicolas Tremblay; Mohammed S Al-Balushi; Ali A Al-Jabri; Daniel Lamarre
Journal:  J Immunol Res       Date:  2018-04-30       Impact factor: 4.818

9.  TRIM14 inhibits hepatitis C virus infection by SPRY domain-dependent targeted degradation of the viral NS5A protein.

Authors:  Shanshan Wang; Yongzhi Chen; Chunfeng Li; Yaoxing Wu; Lei Guo; Changwei Peng; Yueping Huang; Genhong Cheng; F Xiao-Feng Qin
Journal:  Sci Rep       Date:  2016-08-31       Impact factor: 4.379

10.  TRIM34 attenuates colon inflammation and tumorigenesis by sustaining barrier integrity.

Authors:  Qiaoshi Lian; Shanshan Yan; Qi Yin; Chenghua Yan; Wanwei Zheng; Wangpeng Gu; Xinhao Zhao; Weiguo Fan; Xuezhen Li; Liyan Ma; Zhiyang Ling; Yaguang Zhang; Jie Liu; Jinsong Li; Bing Sun
Journal:  Cell Mol Immunol       Date:  2020-02-24       Impact factor: 22.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.